Xiaole Wang

1.9k total citations
83 papers, 1.3k citations indexed

About

Xiaole Wang is a scholar working on Molecular Biology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xiaole Wang has authored 83 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Epidemiology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xiaole Wang's work include Tryptophan and brain disorders (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Autophagy in Disease and Therapy (7 papers). Xiaole Wang is often cited by papers focused on Tryptophan and brain disorders (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Autophagy in Disease and Therapy (7 papers). Xiaole Wang collaborates with scholars based in China, United States and Denmark. Xiaole Wang's co-authors include Yi Zhang, Zhen‐Zhen Wang, Sitong Feng, Nai‐Hong Chen, Yating Wang, Yu‐He Yuan, Hong‐Mei Sun, Jing Peng, Fei Yin and Jie Zhu and has published in prestigious journals such as PLoS ONE, Water Research and Journal of Hazardous Materials.

In The Last Decade

Xiaole Wang

74 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaole Wang China 23 483 166 160 141 139 83 1.3k
Xiaojie Zhang China 24 648 1.3× 136 0.8× 163 1.0× 166 1.2× 55 0.4× 88 1.5k
Jie Ma China 22 451 0.9× 106 0.6× 178 1.1× 99 0.7× 55 0.4× 97 1.3k
Zhigang Miao China 22 658 1.4× 79 0.5× 135 0.8× 141 1.0× 92 0.7× 55 1.3k
Tao Xue China 21 390 0.8× 114 0.7× 192 1.2× 86 0.6× 40 0.3× 102 1.3k
Y Liu China 21 497 1.0× 118 0.7× 132 0.8× 190 1.3× 46 0.3× 75 1.3k
Zizhen Liu China 19 485 1.0× 135 0.8× 387 2.4× 73 0.5× 130 0.9× 48 1.6k
Shuoshuo Li China 15 469 1.0× 140 0.8× 169 1.1× 81 0.6× 148 1.1× 33 1.3k
Hongxia Chen China 21 471 1.0× 108 0.7× 212 1.3× 131 0.9× 68 0.5× 61 1.4k

Countries citing papers authored by Xiaole Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaole Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaole Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaole Wang more than expected).

Fields of papers citing papers by Xiaole Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaole Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaole Wang. The network helps show where Xiaole Wang may publish in the future.

Co-authorship network of co-authors of Xiaole Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaole Wang. A scholar is included among the top collaborators of Xiaole Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaole Wang. Xiaole Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaole, et al.. (2026). Acupotomy Activates PI3K/Akt Signaling Pathway Mediated by FGF7,10/KDR Axis to Regulate Apoptosis. Journal of Pain Research. Volume 19. 1–20.
2.
Wang, Xiaole, et al.. (2025). The Potential Relationship Between Low Back Pain and Depression: A Comprehensive Review. Brain and Behavior. 15(11). e71026–e71026.
3.
Zhang, Ciliu, Zhong-Liang Zhang, Xiaole Wang, et al.. (2025). Gene therapy with covalently closed-end AAV vector for spinal muscular atrophy. Molecular Therapy. 33(10). 4848–4857.
4.
Wang, Xiaole, et al.. (2025). Optimal design and control of trichlorosilane purification process integrated with production of silane through dichlorosilane disproportionation. Separation and Purification Technology. 372. 133446–133446. 1 indexed citations
5.
Pang, Nan, Kuokuo Li, Meilin Chen, et al.. (2023). Targeted sequencing identifies risk variants in 202 candidate genes for neurodevelopmental disorders. Gene. 897. 148071–148071. 1 indexed citations
6.
Zheng, Lingyan, Jiaqi Wu, Xiaole Wang, et al.. (2023). Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease. Phytomedicine. 116. 154890–154890. 25 indexed citations
7.
Wang, Yating, Xiaole Wang, Lei Lan, et al.. (2023). A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression. European Journal of Clinical Pharmacology. 80(2). 287–296. 11 indexed citations
8.
Zhao, Min, Baiyang You, Xiaole Wang, et al.. (2023). Desipramine enhances the stability of atherosclerotic plaque in rabbits monitored with molecular imaging. PLoS ONE. 18(3). e0283612–e0283612. 3 indexed citations
9.
Wang, Xiaole, Yanyan Zhang, Yunxiao Zhang, et al.. (2022). P75 neurotrophin receptor positively regulates the odontogenic/osteogenic differentiation of ectomesenchymal stem cells via nuclear factor kappa-B signaling pathway. Bioengineered. 13(4). 11201–11213. 4 indexed citations
10.
Wang, Xiaole, Sitong Feng, Yating Wang, et al.. (2022). Comparative efficacy and acceptability of drug treatments for Parkinson’s disease with depression: A systematic review with network meta-analysis. European Journal of Pharmacology. 927. 175070–175070. 14 indexed citations
11.
Wang, Xiaole, Sitong Feng, Bin Chen, et al.. (2022). Efficacy and safety of istradefylline for Parkinson’s disease: A systematic review and meta-analysis. Neuroscience Letters. 774. 136515–136515. 3 indexed citations
12.
He, Hailan, Fang He, Leilei Mao, et al.. (2022). Novel HCN1 Mutations Associated With Epilepsy and Impacts on Neuronal Excitability. Frontiers in Molecular Neuroscience. 15. 870182–870182. 9 indexed citations
14.
He, Tiantian, et al.. (2021). The Link between Circadian Clock Genes and Autophagy in Chronic Obstructive Pulmonary Disease. Mediators of Inflammation. 2021(1). 2689600–2689600. 11 indexed citations
15.
Gao, Yating, Xinheng Wang, Xiaole Wang, et al.. (2021). Qiyusanlong Formula Induces Autophagy in Non-Small-Cell Lung Cancer Cells and Xenografts through the mTOR Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 2 indexed citations
16.
Wang, Xiaole, et al.. (2020). <p>LncRNA OR3A4 Regulated the Growth of Osteosarcoma Cells by Modulating the miR-1207-5p/G6PD Signaling</p>. OncoTargets and Therapy. Volume 13. 3117–3128. 28 indexed citations
17.
Peng, Jing, Fei Yin, Xiaolu Deng, et al.. (2019). Ketogenic Diet as a Treatment for Super-Refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome. Frontiers in Neurology. 10. 423–423. 44 indexed citations
18.
Zhang, Mu, et al.. (2018). [Etiology and clinical features of epilepsia partialis continua: an analysis of six cases].. PubMed Central. 20(12). 1008–1014.
19.
20.
Wang, Xiaole, Fang He, Fei Yin, et al.. (2016). The use of targeted genomic capture and massively parallel sequencing in diagnosis of Chinese Leukoencephalopathies. Scientific Reports. 6(1). 35936–35936. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026